Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($1.05), $0.09 better than the analyst estimate of ($1.14). Revenue for the quarter came in at $995 million versus the consensus estimate of $1.18 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.